Caricamento...

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

High-quality, safe, and effective biosimilars have the potential to increase access to biological therapies worldwide and to reduce cancer care costs. The European Medicines Agency (EMA) was the first regulatory authority to establish legislative procedures for the approval of biosimilars when they...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BioDrugs
Autori principali: Aapro, Matti, Krendyukov, Andriy, Schiestl, Martin, Gascón, Pere
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878200/
https://ncbi.nlm.nih.gov/pubmed/29417431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0262-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !